Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrapleural BCG in operable lung cancer.

J Lowe, P B Iles, D F Shore

    Lancet (London, England)
    |January 5, 1980
    PubMed
    Summary

    Intrapleural bacillus Calmette-Guérin (BCG) did not significantly improve survival in patients after lung cancer surgery. The treatment showed minimal adverse effects in this clinical trial.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Language matters: Guidance for person-centred diabetes communication in Ireland.

    Diabetic medicine : a journal of the British Diabetic Association·2026
    Same author

    Ampoules of injectable tranexamic acid are unusable after freezing.

    BMJ military health·2024
    Same author

    The development and acceptability of an educational and training intervention for recruiters to neonatal trials: the TRAIN project.

    BMC medical research methodology·2023
    Same author

    Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: Data from the Australasian Diabetes Data Network registry.

    Diabetic medicine : a journal of the British Diabetic Association·2023
    Same author

    EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients.

    ESMO open·2022
    Same author

    Cylindrospermopsin impairs tubular transport function in kidney cells LLC-PK1.

    Toxicology letters·2021

    Area of Science:

    • Oncology
    • Immunotherapy
    • Thoracic Surgery

    Background:

    • Lung cancer remains a leading cause of cancer mortality worldwide.
    • Adjuvant therapies are crucial for improving outcomes after surgical resection.
    • Intrapleural bacillus Calmette-Guérin (BCG) is investigated as an immunotherapy option.

    Purpose of the Study:

    • To evaluate the efficacy of intrapleural BCG in improving survival after lung cancer resection.
    • To assess the safety and tolerability of intrapleural BCG in this patient population.

    Main Methods:

    • A controlled randomized clinical trial was conducted.
    • 92 patients with surgically resected lung cancer were enrolled.
    • Patients received intrapleural BCG as an adjuvant therapy.

    Main Results:

    • Intrapleural BCG demonstrated no clear beneficial effect on patient survival.
    • The incidence of adverse effects associated with intrapleural BCG was insignificant.

    Conclusions:

    • Intrapleural BCG does not appear to be an effective adjuvant treatment for improving survival in patients with surgically resected lung cancer.
    • The treatment is well-tolerated with minimal adverse events.

    Related Experiment Videos